Recent publications with implications in the field of tolerance.

If you are aware of an recent important publication you would like to see posted here, please contact the ITN webmaster with details.

Am J Transplant (Vol 8, pp 793-802, 2008)
CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath-1H
Bloom DD, et al [read]

Clin Immunol (Vol 126, pp 282-290, 2008)
A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery
Sutter JA, et al [read]

Diabetes (Vol 57, pp 405-414, 2008)
Murine Antithymocyte Globulin Therapy Alters Disease Progression in NOD Mice by a Time-Dependent Induction of Immunoregulation
Simon G, et al [read]

NEJM (Vol 358,pp 353-361, 2008)
HLA-mismatched renal transplantation without maintenance immunosuppression
Kawai T, et al [read]

NEJM (Vol 358, pp 369-374, 2008)
Chimerism and tolerance in a recipient of a deceased-donor liver transplant
Alexander SI, et al [read]

NEJM (Vol 358, pp 362-368, 2008)
Tolerance and chimerism after renal and hematopoietic-cell transplantation
Scandling JD, et al [read]

Trends Immunol (Vol 29, pp 34-40, 2008)
REVIEW: The ‘short’ history of regulatory B cells
Mauri C, Ehrenstein MR [read]

Clin Immunol (Vol 126, pp 189-201, 2008)
A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE
Nicholas MW, et al [read]

Clin Immunol (Vol 126, pp 180-188, 2008)
Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis
Li X, et al [read]

Clin Immunol (Vol 126, pp 180-188, 2008)
Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis
Li X, et al [read]